ArticleFrontiers in cardiovascular medicine2025
Construction and validation of a regularized logistic regression model for predicting late recurrence after ablation in persistent atrial fibrillation: a clinical parameter approach.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictors of atrial fibrillation recurrence after catheter ablation: a systematic review.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with persistent atrial fibrillation (PsAF) exhibit a high recurrence rate following catheter ablation, and there is a lack of individualized prediction tools based on clinical parameters. Objective: To develop and validate a regularized logistic regression model for predicting long-term recurrence risk (>3 months post-procedure) in PsAF patients following catheter ablation. Methods: This study enrolled 300 consecutive PsAF patients undergoing their first radiofrequency catheter ablation (RFCA) from January 2023 to December 2024 in our cardiology department. The first 250 patients were assigned to the training set for model development and internal validation, while the remaining 50 patients served as an independent external validation cohort. Demographic, echocardiographic, laboratory, and procedural parameters were collected. Feature selection was performed using LASSO regression, followed by the construction of a multivariate logistic regression prediction model and a corresponding nomogram. Model performance was evaluated using ROC curves, C-index, and calibration curves. Internal validation was conducted via bootstrap resampling, and external validation was performed on the 50-patient cohort. Results: LASSO regression identified the following predictors: sex, AF duration, preoperative serum calcium, D-dimer, LDL-c, TSH, additional ablation sites, termination mode, early recurrence of atrial fibrillation (ERAF), and creatinine difference. Multivariate analysis revealed pharmacologic termination (OR = 0.248, Conclusion: The regularized logistic regression model incorporating clinical parameters accurately predicts long-term recurrence risk post-ablation in PsAF patients, outperforming traditional risk scoring systems and showing significant potential for clinical application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.